Home/CMTx Biotech/Janet S Lee

JS

Janet S Lee

VP, Clinical Research

Therapeutic Areas

Biodefense Infectious Diseases

CMTx Biotech Pipeline

Drug	Indication	Phase
Incyclinide	CBRN threat / Infectious disease (undisclosed)	Pre-clinical
CMTx R2	Infectious diseases (host-directed treatment)	Pre-clinical

Leadership Team at CMTx Biotech

Co-Founder & Chief Executive Officer

Co-Founder & Chief Operating Officer

Scientific Co-Founder

VP Chemistry, Manufacturing and Controls

Co-Founder & Patient Advocate

View full CMTx Biotech profile